Gentiva Health Services, Inc. is engaged in providing home health services and hospice services. The Company provides home health and hospice services to more than 350,000 patients from more than 420 community locations. Its full range of clinical services includes: skilled nursing, physical, occupational and speech-language therapy, cardiac and pulmonary care, neurorehabilitation, wound care, disease and pain management, medication management and education, patient education to promote self-management, treatment for balance problems that can lead to fall risks and hospice services. The Company's Hospice segment serves terminally ill patients and their families through more than 150 locations operating in 29 states. Hospice operations are also organized in a single division, which is staffed with clinical, operational, human resource, finance and sales teams.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Health Care Providers & Services
- Sub-Industry: Health Care Services
- Symbol: NASDAQ:GTIV
- CUSIP: 37247A10
- Web: N/A
- 50 Day Moving Avg: $19.00
- 200 Day Moving Avg: $19.00
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 15.99
- P/E Growth: 0
Frequently Asked Questions for Gentiva Health Services (NASDAQ:GTIV)
What is Gentiva Health Services' stock symbol?
Gentiva Health Services trades on the NASDAQ under the ticker symbol "GTIV."
How were Gentiva Health Services' earnings last quarter?
Gentiva Health Services, Inc. (NASDAQ:GTIV) issued its earnings results on Friday, November, 14th. The company reported $0.28 EPS for the quarter, hitting analysts' consensus estimates of $0.28. The firm had revenue of $498.01 million for the quarter, compared to analyst estimates of $498 million. View Gentiva Health Services' Earnings History.
Who are some of Gentiva Health Services' key competitors?
Some companies that are related to Gentiva Health Services include Merck KGaA (MKGAY), Hospira (HSP), Omnicare (OCR), Health Net (HNT), WuXi PharmaTech (Cayman) (WX), Hanger (HGR), SIGA Technologies (SIGA), Nobilis Health Corp (HLTH), Verastem (VSTM), Palatin Technologies (PTN), KaloBios Pharmaceuticals (KBIO), AdCare Health Systems (ADK), Capricor Therapeutics (CAPR), 3SBio (SSRX), Alexza Pharmaceuticals (ALXA), Allergan plc (WPI), Allergan plc (ACT) and Allos Therapeutics (ALTH).
How do I buy Gentiva Health Services stock?
Shares of Gentiva Health Services can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Gentiva Health Services stock cost?
One share of Gentiva Health Services stock can currently be purchased for approximately $19.19.
Consensus Ratings for Gentiva Health Services (NASDAQ:GTIV) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Gentiva Health Services (NASDAQ:GTIV)
(Data available from 5/27/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|11/26/2015||Robert W. Baird||Upgrade||Underperform -> Neutral||N/A|
Earnings History for Gentiva Health Services (NASDAQ:GTIV)Earnings History by Quarter for Gentiva Health Services (NASDAQ:GTIV)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/14/2014||Q3 2014||$0.28||$0.28||$498.00 million||$498.01 million||View||N/A|
|8/5/2014||Q214||$0.24||$0.38||$492.31 million||$498.00 million||View||N/A|
|5/7/2014||Q114||$0.11||$0.13||$491.51 million||$487.50 million||View||N/A|
|3/4/2014||Q413||$0.30||($0.14)||$496.51 million||$486.10 million||View||N/A|
|8/1/2013||Q2 2013||$0.21||$0.22||$416.83 million||$414.40 million||View||N/A|
|5/9/2013||Q1 2013||$0.30||$0.23||$427.95 million||$415.60 million||View||N/A|
|2/7/2013||Q4 2012||$0.34||$0.31||$432.77 million||$425.00 million||View||N/A|
|11/1/2012||Q312||$0.28||$0.32||$428.44 million||$424.40 million||View||N/A|
Earnings Estimates for Gentiva Health Services (NASDAQ:GTIV)
Current Year EPS Consensus Estimate: $1.05 EPS
Next Year EPS Consensus Estimate: $1.20 EPS
Dividend History for Gentiva Health Services (NASDAQ:GTIV)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Gentiva Health Services (NASDAQ:GTIV)Insider Trades by Quarter for Gentiva Health Services (NASDAQ:GTIV)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/25/2013||David Causby||EVP||Sell||9,223||$12.25||$112,981.75|| |
|6/17/2013||Rodney D Windley||Chairman||Sell||10,000||$11.73||$117,300.00|| |
|5/15/2013||Rodney D Windley||Chairman||Sell||10,000||$10.39||$103,900.00|| |
|2/15/2013||John N Camperlengo||SVP||Sell||6,000||$11.50||$69,000.00|| |
|2/15/2013||Rodney D Windley||Chairman||Sell||10,000||$11.31||$113,100.00|| |
Headline Trends for Gentiva Health Services (NASDAQ:GTIV)
Latest Headlines for Gentiva Health Services (NASDAQ:GTIV)
Gentiva Health Services (GTIV) Chart for Saturday, May, 27, 2017